المؤلفون: G. E. Chernukha, M. R. Dumanovskaya, G. I. Tabeeva

المصدر: Медицинский совет, Vol 0, Iss 12, Pp 126-130 (2016)

مصطلحات موضوعية: myoma, uliprastal acetate, progesterone receptor selective modulator, Medicine

وصف الملف: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/1445; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

URL الوصول: https://doaj.org/article/2b4d1f6c9b324d0c8f8aac044a35c9bf

المؤلفون: M. R. Dumanovskaya, G. I. Tabeeva, М. Р. Думановская, Г. И. Табеева

المصدر: Meditsinskiy sovet = Medical Council; № 6 (2023); 144-149 ; Медицинский Совет; № 6 (2023); 144-149 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: этинилэстрадиол, reproductive health, intravaginal drug delivery system, vaginal microbiota, etonogestrel, ethinylestradiol, репродуктивное здоровье, интравагинальный метод доставки лекарственных средств, микробиота влагалища, этоногестрел

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7500/6689; Bearak J., Popinchalk A., Ganatra B., Moller A.B., Tunçalp Ö., Beavin C. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob Health. 2020;8(9):e1152–e1161. https://doi.org/10.1016/S2214-109X(20)30315-6.; Смелов П.А., Никитина С.Ю., Агеева Л.И., Александрова Г.А., Голубев Н.А., Кириллова Г.Н. и др. Здравоохранение в России. М.; 2021. 171 с. Режим доступа: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf.; Kantorová V., Wheldon M.C., Ueffing P., Dasgupta A.N.Z. Estimating progress towards meeting women’s contraceptive needs in 185 countries: A Bayesian hierarchical modelling study. PLoS Med. 2020;17(2):e1003026. https://doi.org/10.1371/journal.pmed.1003026.; Fan G.S., Ren M., Di W., Su P., Chang Q., Wu S. et al. Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial. Eur J Contracept Reprod Health Care. 2016;21(4):303–309. https://doi.org/10.1080/13625187.2016.1186269.; Адану Р., Амарал Е.,Ами Дж.-Дж., Камерон Ш., Чипато Т., Чу Р. и др. Медицинские критерии приемлемости для использования методов контрацепции. М.; 2015. 192 с. Режим доступа: https://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/en.; Lete I., Doval J.L., Pérez-Campos E., Lertxundi R., Correa M., de la Viuda E. et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception. 2008;77(4):276–282. https://doi.org/10.1016/j.contraception.2007.11.009.; Nguyen B.T., Jensen J.T. Evaluating the efficacy and safety of a progestinand estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring. Expert Opin Drug Saf. 2014;13(10):1423–1430. https://doi.org/10.1517/14740338.2014.948842.; Wieder D.R., Pattimakiel L. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). Int J Womens Health. 2010;2:401–409. https://doi.org/10.2147/IJWH.S6162.; Lete I., Dueñas J.L., Esplugues J.V., Marti-Cabrera M. Is the vagina an adequate route for the administration of hormonal contraceptives? Curr Drug Metab. 2010;11(10):839–849. https://doi.org/10.2174/138920010794479646.; Teal S., Edelman A. Contraception Selection, Effectiveness, and Adverse Effects: A Review. JAMA. 2021;326(24):2507–2518. https://doi.org/10.1001/jama.2021.21392.; Delvaux T., Jespers V., Benova L., van de Wijgert J. Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis. Front Glob Womens Health. 2021;2:799963. https://doi.org/10.3389/fgwh.2021.799963.; Timmer C.J., Mulders T.M. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000;39(3):233–242. https://doi.org/10.2165/00003088-200039030-00005.; Mansour D., Inki P., Gemzell-Danielsson K. Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care. 2010;15(1):4–16. https://doi.org/10.3109/13625180903427675.; López-Picado A., Lapuente O., Lete I. Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2017;22(2):131–146. https://doi.org/10.1080/13625187.2017.1287351.; Ridgeway K., Montgomery E.T., Smith K., Torjesen K., van der Straten A., Achilles S.L. et al. Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception. 2022;106:16–33. https://doi.org/10.1016/j.contraception.2021.10.001.; Griffin J.B., Ridgeway K., Montgomery E., Torjesen K., Clark R., Peterson J. et al. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. PLoS ONE. 2019;14(11):e0224898. https://doi.org/10.1371/journal.pone.0224898.; Vargas S.E., Midoun M.M., Guillen M., Getz M.L., Underhill K., Kuo C. et al. A Qualitative Systematic Review of Women’s Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies. Perspect Sex Reprod Health. 2019;51(2):71–80. https://doi.org/10.1363/psrh.12103.; Novák A., de la Loge C., Abetz L., van der Meulen E.A. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 2003;67(3):187–194. https://doi.org/10.1016/s0010-7824(02)00514-0.; Novák A., de la Loge C., Abetz L. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing. Pharmacoeconomics. 2004;22(4):245–256. https://doi.org/10.2165/00019053-200422040-00003.; McLellan-Lemal E., Ondeng’e K., Gust D.A., Desai M., Otieno F.O., Madiega P.A. et al. Contraceptive vaginal ring experiences among women and men in Kisumu, Kenya: A qualitative study. Front Womens Health. 2017;2(1):10.15761/FWH.1000122. https://doi.org/10.15761/FWH.1000122.; Kestelyn E., Van Nuil J.I., Umulisa M.M., Umutoni G., Uwingabire A., Mwambarangwe L. et al. Ring Plus Study Group. High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda. PLoS ONE. 2018;13(6):e0199096. https://doi.org/10.1371/journal.pone.0199096; Sivin I., Mishell D.R.Jr., Alvarez F., Brache V., Elomaa K., Lähteenmäki P. et al. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. Contraception. 2005;71(2):122–129. https://doi.org/10.1016/j.contraception.2004.08.010.; Weisberg E., Fraser I.S., Mishell D.R.Jr., Lacarra M., Bardin C.W. The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. Contraception. 1995;51(1):39–44. https://doi.org/10.1016/0010-7824(94)00005-H.; Schafer J.E., Osborne L.M., Davis A.R., Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception. 2006;73(5):488–492. https://doi.org/10.1016/j.contraception.2005.11.003.; Merki-Feld G.S., Hund M. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use. Eur J Contracept Reprod Health Care. 2010;15(6):413–422. https://doi.org/10.3109/13625187.2010.524717.; Pandit S.N., Chauhan A.R., Anagani M., Reddy S., Birla A., Ray S.K. Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women. J Obstet Gynaecol India. 2014;64(6):409–416. https://doi.org/10.1007/s13224-014-0559-7.; Roumen F.J., op ten Berg M.M., Hoomans E.H. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands. Eur J Contracept Reprod Health Care. 2006;11(1):14–22. https://doi.org/10.1080/13625180500389547.; Creinin M.D., Meyn L.A., Borgatta L., Barnhart K., Jensen J., Burke A.E. et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol. 2008;111(1):267–277. https://doi.org/10.1097/01.AOG.0000298338.58511.d1.; Ahrendt H.J., Nisand I., Bastianelli C., Gómez M.A., Gemzell-Danielsson K., Urdl W. et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006;74(6):451–47. https://doi.org/10.1016/j.contraception.2006.07.004.; Gilliam M.L., Neustadt A., Kozloski M., Mistretta S., Tilmon S., Godfrey E. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial. Obstet Gynecol. 2010;115(3):503–510. https://doi.org/10.1097/AOG.0b013e3181cf45dc.; Battaglia C., Morotti E., Persico N., Battaglia B., Busacchi P., Casadio P. et al. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study. J Sex Med. 2014;11(2):471–480. https://doi.org/10.1111/jsm.12392.; Guida M., Di Spiezio Sardo A., Bramante S., Sparice S., Acunzo G., Tommaselli G.A. et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod. 2005;20(4):1100–1106. https://doi.org/10.1093/humrep/deh686.; Guida M., Cibarelli F., Troisi J., Gallo A., Palumbo A.R., Di Spiezio Sardo A. Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration. Arch Gynecol Obstet. 2014;290(6):1239–1247. https://doi.org/10.1007/s00404-014-3323-4.; Elaut E., Buysse A., De Sutter P., De Cuypere G., Gerris J., Deschepper E. et al. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception. 2012;85(5):470–479. https://doi.org/10.1016/j.contraception.2011.10.007.; Sabatini R., Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006;74(3):220–223. https://doi.org/10.1016/j.contraception.2006.03.022.; Roumen F.J.M.E., Apter D., Mulders T.M.T., Dieben T.O.M. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyloestradiol. Hum Reprod. 2001;16(3):469–475. https://doi.org/10.1093/humrep/16.3.469.; Lete I., Cuesta M.C., Marín J.M., Guerra S. Vaginal health in contraceptive vaginal ring users – A review. Eur J Contracept Reprod Health Care. 2013;18(4):234–241. https://doi.org/10.3109/13625187.2013.801954.; Rock J.A., Thompson J.D. TeLinde’s operative gynecology. 8th ed. Philadelphia, PA: Lipincott-Raven; 1977.; Brabaharan S., Veettil S.K., Kaiser J.E., Raja R.V.R., Wattanayingcharoenchai R., Maharajan M. et al. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open. 2022;5(1):e2143730. https://doi.org/10.1001/jamanetworkopen.2021.43730.; Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. https://doi.org/10.15585/mmwr.rr7004a1.; Crucitti T., Hardy L., van de Wijgert J., Agaba S., Buyze J., Kestelyn E. et al. Ring Plus study group. Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women. PLoS ONE. 2018;13(7):e0201003. https://doi.org/10.1371/journal.pone.0201003.; Veres S., Miller L., Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol. 2004;104(3):555–563. https://doi.org/10.1097/01.AOG.0000136082.59644.13.; Lopez L.M., Grimes D.A., Gallo M.F., Stockton L.L., Schulz K.F. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013;2013(4):CD003552. https://doi.org/10.1002/14651858.CD003552.pub4.; Kestelyn E., Agaba S., Van Nuil J.I., Uwineza M., Umulisa M.M., Mwambarangwe L. et al. A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use. PLoS ONE. 2018;13(6):e0197572. https://doi.org/10.1371/journal.pone.0197572.; Chassot F., Camacho D.P., Patussi E.V., Donatti L., Svidzinski T.I., Consolaro M.E. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring? Contraception. 2010;81(4):331–335. https://doi.org/10.1016/j.contraception.2009.12.011.; Asthana S., Busa V., Labani S. Oral contraceptives use and risk of cervical cancer – a systematic review & metaanalysis. Eur J Obstet Gynecol Reprod Biol. 2020;247:163–175. https://doi.org/10.1016/j.ejogrb.2020.02.014.; FSRH Guideline (January 2019) Combined Hormonal Contraception (Revision due by January 2024). BMJ Sex Reprod Health. 2019;45(1):1–93. https://doi.org/10.1136/bmjsrh-2018-CHC.; Archer D., Raine T., Darney P. An open-label noncomparative study to evaluate the vagina and cervix of NuvaRing® users. Fertil Steril. 2002;76(1):S25. https://doi.org/10.1016/S0015-0282(02)03446-5.; https://www.med-sovet.pro/jour/article/view/7500

الاتاحة: https://www.med-sovet.pro/jour/article/view/7500
https://doi.org/10.21518/ms2023-092

المؤلفون: G E Chernukha, D V Gusev, G I Tabeeva, V Yu Prilutskaia

المصدر: Гинекология, Vol 20, Iss 1, Pp 16-22 (2018)

مصطلحات موضوعية: anorexia nervosa, amenorrhea, eating disorders, leptin, Gynecology and obstetrics, RG1-991

Relation: https://gynecology.orscience.ru/2079-5831/article/viewFile/30026/pdf; https://doaj.org/toc/2079-5696; https://doaj.org/toc/2079-5831; https://doaj.org/article/7fc0c892c3be4bd9b85d187e3b85e54c

الاتاحة: https://doi.org/10.26442/2079-5696_20.1.16-22
https://doaj.org/article/7fc0c892c3be4bd9b85d187e3b85e54c

المؤلفون: G E Chernukha, D V Gusev, Yu B Moskvicheva, G I Tabeeva

المصدر: Гинекология, Vol 19, Iss 2, Pp 15-18 (2017)

مصطلحات موضوعية: energy balance, menstrual cycle, amenorrhea, nutrition, leptin, body fat, Gynecology and obstetrics, RG1-991

Relation: https://gynecology.orscience.ru/2079-5831/article/viewFile/28602/pdf; https://doaj.org/toc/2079-5696; https://doaj.org/toc/2079-5831; https://doaj.org/article/2e027070da3441b3b7604ce0b2f5914b

الاتاحة: https://doaj.org/article/2e027070da3441b3b7604ce0b2f5914b

المؤلفون: G I Tabeeva, L A Marchenko, L B Butareva, Z G Gabibullaeva

المصدر: Гинекология, Vol 11, Iss 1, Pp 55-59 (2009)

مصطلحات موضوعية: Gynecology and obstetrics, RG1-991

Relation: https://gynecology.orscience.ru/2079-5831/article/view/28000; https://doaj.org/toc/2079-5696; https://doaj.org/toc/2079-5831; https://doaj.org/article/4652bb4e1d514d2ab0b0509d15100533

الاتاحة: https://doaj.org/article/4652bb4e1d514d2ab0b0509d15100533

المؤلفون: Yu B, Moskvicheva, D V, Gusev, G I, Tabeeva, G E, Chernukha

المصدر: Voprosy pitaniia. 87(1)

مصطلحات موضوعية: Adult, Leptin, Body Composition, Dietary Carbohydrates, Humans, Nutritional Status, Female, Dietary Proteins, Feeding Behavior, Energy Metabolism, Amenorrhea, Hypothalamic Diseases, Body Mass Index

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::384e2380d39df5d6e89623811f66b3d8
https://pubmed.ncbi.nlm.nih.gov/30592846

المؤلفون: D V Gusev, Yu B Moskvicheva, G I Tabeeva, G E Chernukha

المصدر: Гинекология, Vol 19, Iss 2, Pp 15-18 (2017)

مصطلحات موضوعية: medicine.diagnostic_test, business.industry, Leptin, media_common.quotation_subject, Obstetrics and Gynecology, Physiology, Nutritional status, Hypothalamic amenorrhea, energy balance, leptin, lcsh:Gynecology and obstetrics, menstrual cycle, amenorrhea, body fat, nutrition, Medicine, Amenorrhea, Drive for thinness, medicine.symptom, business, Lipid profile, lcsh:RG1-991, Menstrual cycle, media_common, Body dissatisfaction

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae16385dc7f0c9035564b81f1467f63
https://doi.org/10.26442/2079-5696_19.2.15-18